4.18 -0.02 (-0.48%)
RGEN
| Trade RGEN now with |
|
Stock Details
Last Trade:4.18 Change:-0.02 (-0.48%) Prev Close:4.20 Open: 4.21 Days Range:4.18 – 4.23 52 Week Range: 2.90 - 5.31 Volume:2325 P/E: N/AEPS:-0.03
View AllRecent Alerts 02/09/12
Recent Alert on 12/21/11 at 7:35am
Repligen (RGEN) Submits SecreFlo NDA to FDA
Repligen (RGEN) Submits SecreFlo NDA to FDA
Repligen Corporation (Nasdaq: RGEN) has submitted a New Drug Application (NDA) for SecreFlo (RG1068, synthetic human secretin) to improve detection of pancreatic duct abnormalities in combination with MRI in patients with pancreatitis. Structural... Read More
Recent Alert on 12/20/11 at 8:22am
Repligen (RGEN) Completes $22.7M Acquisition of Novozymes Biopharma; Additional EUR 16M in Milestones Possible
Repligen (RGEN) Completes $22.7M Acquisition of Novozymes Biopharma; Additional EUR 16M in Milestones Possible
Recent Alert on 12/20/11 at 8:22am
Repligen (RGEN) Completes $22.7M Acquisition of Novozymes Biopharma; Additional EUR 16M in Milestones Possible
Repligen (RGEN) Completes $22.7M Acquisition of Novozymes Biopharma; Additional EUR 16M in Milestones Possible
Recent Alert on 12/20/11 at 8:22am
Repligen (RGEN) Completes $22.7M Acquisition of Novozymes Biopharma; Additional EUR 16M in Milestones Possible
Repligen (RGEN) Completes $22.7M Acquisition of Novozymes Biopharma; Additional EUR 16M in Milestones Possible
View AllRecent Press Releases
Press Release on 02/09/12 at 10:58am
Repligen Announces Conference Call of Preliminary Third Quarter Fiscal Year 2012 Results
Repligen Announces Conference Call of Preliminary Third Quarter Fiscal Year 2012 Results
View AllRecent SEC Filings
No Recent SEC Filings Available